News and Trends 13 Dec 2017
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy originally developed by Cellectis, might struggle to outperform autologous CAR-T cells. CAR-T cell therapy has…